Kenneth J.  Fasola net worth and biography

Kenneth Fasola Biography and Net Worth

President of Centene

Ken Fasola serves as President of Centene Corporation, playing a key role working alongside CEO Sarah London in positioning Centene as a healthcare leader. Prior to serving as President, Fasola was Centene's Executive Vice President of Health Care Enterprises and a member of the Office of the CEO.

Fasola joined Centene through the company’s acquisition of Magellan Health Inc., where he served as CEO and a member of the Board of Directors. Prior to his work at Magellan, Fasola was Chairman, President, and CEO of HealthMarkets, Inc., one of the largest health insurance agencies and supplemental insurance companies in the U.S. He also spent nearly 20 years in executive leadership roles at UnitedHealth Group and Humana.

Fasola holds a Bachelor of Science in health planning and administration from Pennsylvania State University and was named an Alumni Fellow in 2010.

What is Kenneth J. Fasola's net worth?

The estimated net worth of Kenneth J. Fasola is at least $17.45 million as of May 13th, 2024. Mr. Fasola owns 300,357 shares of Centene stock worth more than $17,450,742 as of November 13th. This net worth evaluation does not reflect any other investments that Mr. Fasola may own. Additionally, Mr. Fasola receives a salary of $4,670,000.00 as President at Centene. Learn More about Kenneth J. Fasola's net worth.

How old is Kenneth J. Fasola?

Mr. Fasola is currently 64 years old. There are 6 older executives and no younger executives at Centene. Learn More on Kenneth J. Fasola's age.

What is Kenneth J. Fasola's salary?

As the President of Centene Co., Mr. Fasola earns $4,670,000.00 per year. The highest earning executive at Centene is Ms. Sarah M. London, CEO & Director, who commands a salary of $4,980,000.00 per year. Learn More on Kenneth J. Fasola's salary.

How do I contact Kenneth J. Fasola?

The corporate mailing address for Mr. Fasola and other Centene executives is 7700 FORSYTH BOULEVARD, ST LOUIS MO, 63105. Centene can also be reached via phone at (314) 725-4477 and via email at [email protected]. Learn More on Kenneth J. Fasola's contact information.

Has Kenneth J. Fasola been buying or selling shares of Centene?

Kenneth J. Fasola has not been actively trading shares of Centene during the last quarter. Most recently, Kenneth J. Fasola sold 8,000 shares of the business's stock in a transaction on Monday, May 13th. The shares were sold at an average price of $77.62, for a transaction totalling $620,960.00. Following the completion of the sale, the president now directly owns 300,357 shares of the company's stock, valued at $23,313,710.34. Learn More on Kenneth J. Fasola's trading history.

Who are Centene's active insiders?

Centene's insider roster includes Andrew Asher (Exec. VP & CFO ), Andrew Asher (CFO), Orlando Ayala (Director), Shannon Bagley (EVP), Mark Brooks (EVP), Kenneth Burdick (EVP), Brandy Burkhalter (COO), Katie Casso (SVP), Christopher Coughlin (Director), Robert Ditmore (Director), Kenneth Fasola (President), Richard Gephardt (Director), Jesse Hunter (NASDAQ), Christopher Koster (SVP), Brent Layton (EVP), Sarah London (CEO), Michael Neidorff (CEO), John Roberts (Director), Lori Robinson (Director), Theodore Samuels, II (Director), Jeffrey Schwaneke (CFO), David Thomas (EVP), Tommy Thompson (Director), and Colin Toney (EVP). Learn More on Centene's active insiders.

Are insiders buying or selling shares of Centene?

In the last twelve months, Centene insiders bought shares 1 times. They purchased a total of 4,117 shares worth more than $250,313.60. In the last twelve months, insiders at the sold shares 4 times. They sold a total of 30,878 shares worth more than $2,363,286.50. The most recent insider tranaction occured on November, 8th when CEO Sarah London bought 4,117 shares worth more than $250,313.60. Insiders at Centene own 0.3% of the company. Learn More about insider trades at Centene.

Information on this page was last updated on 11/8/2024.

Kenneth J. Fasola Insider Trading History at Centene

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/13/2024Sell8,000$77.62$620,960.00300,357View SEC Filing Icon  
2/7/2024Sell12,000$75.07$900,840.00235,365View SEC Filing Icon  
See Full Table

Kenneth J. Fasola Buying and Selling Activity at Centene

This chart shows Kenneth J Fasola's buying and selling at Centene by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Centene Company Overview

Centene logo
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support. This segment also provides healthcare products. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. It also operates clinical healthcare and pharmacies, as well as offers dental and speech therapy services. In addition, the company engages in the government contracts business under the TRICARE program and other healthcare related government contracts. It provides services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in Saint Louis, Missouri.
Read More

Today's Range

Now: $58.04
Low: $57.56
High: $59.19

50 Day Range

MA: $68.91
Low: $58.60
High: $76.57

2 Week Range

Now: $58.04
Low: $57.56
High: $81.42

Volume

6,850,071 shs

Average Volume

3,969,779 shs

Market Capitalization

$29.30 billion

P/E Ratio

10.08

Dividend Yield

N/A

Beta

0.49